We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Provider of VNAs for Oncology Sites Reaches Significant Milestone

By MedImaging International staff writers
Posted on 26 Sep 2016
Print article
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
A large diagnostic imaging products and medical informatics solutions provider has announced that they have reached a milestone in the number of installations of their enterprise-wide medical information and image management Vendor Neutral Archive (VNA).

The company has installed more than 300 of the scalable VNA storage systems, used for managing cancer treatment data, at oncology sites around the world. The VNA manages all DICOM (Digital Imaging and Communications in Medicine) and non-DICOM clinical oncology department data, used in the treatment of cancer patients. The data includes radiology diagnostic images, radiation treatment plans, and other clinical data. The oncology facilities that use the Synapse VNA interface more than 800 linear accelerators (linacs).

FUJIFILM Medical Systems U.S.A. (Stamford, CT, USA) developed the Synapse VNA technology interface. The company is also a leading worldwide provider of diagnostic imaging products, and medical informatics solutions, including digital X-Ray systems, Radiology Information Systems (RIS), the Synapse PACS (Picture Archiving and Communication System), cardiovascular products, and advanced imaging systems for the women’s health market. The Synapse VNA enables clinicians to access and securely share the data and back it up, with disaster recovery capabilities.

VP of FUJIFILM Medical Systems TeraMedica Division USA, Greg Strowig, said, “Fujifilm truly dominates the oncology VNA space both for our innovative technology and also our knowledge of what it takes to deliver better cancer care. Cancer centers across the globe have turned to us because of our unparalleled experience with the management of cancer treatment data.”

Related Links:
FUJIFILM Medical Systems U.S.A.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Doppler System
Doppler BT-200
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.